Style | Citing Format |
---|---|
MLA | Malek M, et al.. "Atorvastatin Enhances the Antitumor Activity of Tamoxifen in B16f10 Mouse Melanoma Cell Lines." Physiology and Pharmacology (Iran), vol. 25, no. 1, 2021, pp. 83-91. |
APA | Malek M, Ghasemi M, Vaseghi G, Ghasemi A, Esfahani HN, Dana N, Javanmard SH (2021). Atorvastatin Enhances the Antitumor Activity of Tamoxifen in B16f10 Mouse Melanoma Cell Lines. Physiology and Pharmacology (Iran), 25(1), 83-91. |
Chicago | Malek M, Ghasemi M, Vaseghi G, Ghasemi A, Esfahani HN, Dana N, Javanmard SH. "Atorvastatin Enhances the Antitumor Activity of Tamoxifen in B16f10 Mouse Melanoma Cell Lines." Physiology and Pharmacology (Iran) 25, no. 1 (2021): 83-91. |
Harvard | Malek M et al. (2021) 'Atorvastatin Enhances the Antitumor Activity of Tamoxifen in B16f10 Mouse Melanoma Cell Lines', Physiology and Pharmacology (Iran), 25(1), pp. 83-91. |
Vancouver | Malek M, Ghasemi M, Vaseghi G, Ghasemi A, Esfahani HN, Dana N, et al.. Atorvastatin Enhances the Antitumor Activity of Tamoxifen in B16f10 Mouse Melanoma Cell Lines. Physiology and Pharmacology (Iran). 2021;25(1):83-91. |
BibTex | @article{ author = {Malek M and Ghasemi M and Vaseghi G and Ghasemi A and Esfahani HN and Dana N and Javanmard SH}, title = {Atorvastatin Enhances the Antitumor Activity of Tamoxifen in B16f10 Mouse Melanoma Cell Lines}, journal = {Physiology and Pharmacology (Iran)}, volume = {25}, number = {1}, pages = {83-91}, year = {2021} } |
RIS | TY - JOUR AU - Malek M AU - Ghasemi M AU - Vaseghi G AU - Ghasemi A AU - Esfahani HN AU - Dana N AU - Javanmard SH TI - Atorvastatin Enhances the Antitumor Activity of Tamoxifen in B16f10 Mouse Melanoma Cell Lines JO - Physiology and Pharmacology (Iran) VL - 25 IS - 1 SP - 83 EP - 91 PY - 2021 ER - |